![Synlogic, Inc. logo](/logos/SYBX.webp)
Synlogic, Inc.
NASDAQ:SYBX
Overview | Financials
Company Name | Synlogic, Inc. |
Symbol | SYBX |
Currency | USD |
Price | 1.45 |
Market Cap | 16,959,345 |
Dividend Yield | 0% |
52-week-range | 0.234 - 5.708 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Aoife M. Brennan BAO, BCh, M.D., MB, MMSc |
Website | https://www.synlogictx.com |
An error occurred while fetching data.
About Synlogic, Inc.
Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase II clinical trials to treat
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD